Prophylactic vs. therapeutic magnesium sulfate for shivering during spinal anesthesia

Autor: Ibrahim T. Ibrahim, Soheir A. Megalla, Omyma Sh.M. Khalifa, Hala M. salah El Deen
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Zdroj: Egyptian Journal of Anaesthesia, Vol 30, Iss 1, Pp 31-37 (2014)
Druh dokumentu: article
ISSN: 1110-1849
DOI: 10.1016/j.egja.2013.07.007
Popis: Introduction: Shivering is one of the most common complications of neuraxial blockade. Some patients find shivering sensation worse than surgical pain. Therefore, both prevention and treatment of established shivering should be regarded as clinically relevant intervention in the perioperative period. The aim of our study is to compare the efficacy of magnesium sulfate when used for prevention or treatment of shivering following spinal anesthesia. Methods: In this prospective, double blind, placebo controlled study, 120 ASA I, II patients undergoing surgery under spinal anesthesia were randomized into 3 groups. Following intrathecal injection, Group P (prophylactic) was given MgSO4, 50 mg/kg I.V. bolus + 2 mg/kg/h infusion. Group T (therapeutic) was given MgSO4 50 mg/kg I.V. bolus as a therapy when shivering occurred. If shivering persisted, they received 25 mg/kg I.V. bolus. Group C (control) received saline at identical times. Meperidine was given as rescue if shivering persisted. Shivering grade 3/4 was regarded as significant. Core temperatures, incidence of shivering, and side effects were recorded. Main results: Total incidence of shivering, grade 3/4, was 15% in Group P, 45% in Group T, and 50% in Group C (p
Databáze: Directory of Open Access Journals